Report on the EAN Regional Teaching Day of the Estonian Ludvig Puusepp Society of Neurologists and Neurosurgeons, held on 2 June, adjacent to the society's annual congress.
-
-
EAN President Paul Boon and ESNR President Tarek Yousry are pleased to announce that a Memorandum of Understanding has been signed between the EAN and ESNR. -
Make the most of your research by publishing in the official EAN journal, with double-digit annual growth in submissions and readership. -
EAN StaffEAN NewsEAN NewsTop ArticlesCelebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!
This year marks a great occasion in the history of our organization as we proudly celebrate the 20-year work anniversary of EAN's Executive Director, Anja Sander! -
EAN NewsNews in generalEAN NewsOther NewsWHO recognises the public health need for effective and affordable treatments for multiple sclerosis
On 26 July, the World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc) which include important new medicines for the treatment of multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions, among others. -
AdvocacyBrain HealthEAN NewsEAN NewsOther NewsBrain Health Mission Booth at the EAN Congress 2023 in Budapest
The Brain Health Mission was an unmissable feature of the exhibition at the EAN Congress 2023 in Budapest. With its bicycle-powered smoothie maker, reading lounge, and giveaways, the bright green stand attracted lots of comments - literally, written all over its walls! -
Re-live some of the highlights of the EAN Congress 2023 with our Congress Review, full of session reports, photos, facts and figures from Europe’s biggest neurology meeting. -
Executive PageEAN NewsEAN Congress newsFeatured SliderExecutive Page: Thank you for making the EAN Congress 2023 a great success!
EAN President Paul Boon looks back at the 9th Congress of the European Academy of Neurology, which took place in Budapest on 1-4- July. -
Paper of the MonthEAN NewsResearchFeatured SliderResearch Paper of the Month: Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Our paper of the month is a phase 3, double-blind, multicentre, trial investigating the efficacy and the safety of vorasidenib, a dual inhibitor of the IDH1 and IHD2 enzymes, in patients with residual or recurrent IDH mutant grade 2 gliomas. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2023. -
World Brain Day is an annual event observed on July 22, aimed at promoting awareness and education for neurological disorders that affect individuals worldwide. In 2023, a key focus of World Brain Day is on Brain Health and Disability. It… Continue Reading -
EAN NewsResident and Research FellowsEducation cornerEAN Mentorship Programme – workshop at EAN 2023 in Budapest
All neurologists interested in learning more about mentorship are invited to join this highly informative and interactive workshop at EAN 2023, hosted by two members of the EAN Mentorship Task Force. -
Executive PageEAN NewsEAN Congress newsFeatured SliderExecutive Page: Get ready for EAN 2023 in Budapest!
Programme Committee Chair, Ulf Kallweit, provides a preview of the 9th Annual Congress of the European Academy of Neurology, in Budapest on 1-4 July. -
Paper of the MonthEAN NewsResearchFeatured Slider
Research Papers of the Month: Safety and efficacy of rozanolixizumab/zilucoplan in patients with generalised myasthenia gravis (MycarinG and RAISE)
This month we have selected two papers of the month, reporting the results of two randomised, double-blind, placebo-controlled, phase III trials investigating potential therapies for generalised Myasthenia Gravis. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2023.